Patient-Care Practices Associated with an Increased Prevalence of Hepatitis C Virus Infection among Chronic Hemodialysis Patients

Objective. To identify patient-care practices related to an increased prevalence of hepatitis C virus (HCV) infection among chronic hemodialysis patients. Design. Survey. Setting. Chronic hemodialysis facilities in the United States. Participants. Equal-probability 2-stage cluster sampling was used to select 87 facilities from all Medicare-approved providers treating 30–150 patients; 53 facilities and 2,933 of 3,680 eligible patients agreed to participate. Methods. Patients were tested for HCV antibody and HCV RNA. Data on patient-care practices were collected using direct observation. Results. The overall prevalence of HCV infection was 9.9% (95% confidence interval [CI], 8.2%–11.6%); only 2 of 294 HCV-positive patients were detected solely by HCV RNA testing. After adjusting for non-dialysis-related HCV risk factors, patient-care practices independently associated with a higher prevalence of HCV infection included reusing priming receptacles without disinfection (odds ratio [OR], 2.3 [95% CI, 1.4–3.9]), handling blood specimens adjacent to medications and clean supplies (OR, 2.2 [95% CI, 1.3–3.6]), and using mobile carts to deliver injectable medications (OR, 1.7 [95% CI, 1.0–2.8]). Independently related facility covariates were at least 10% patient HCV infection prevalence (OR, 3.0 [95% CI, 1.8–5.2]), patient-to-staff ratio of at least 7: 1 (OR, 2.4 [95% CI, 1.4–4.1]), and treatment duration of at least 2 years (OR, 2.4 [95% CI, 1.3–4.4]). Conclusions. This study provides the first epidemiologic evidence of associations between specific patient-care practices and higher HCV infection prevalence among hemodialysis patients. Staff should review practices to ensure that hemodialysis-specific infection control practices are being implemented, especially handling clean and contaminated items in separate areas, reusing items only if disinfected, and prohibiting mobile medication and clean supply carts within treatment areas.

[1]  N. Fishman,et al.  Healthcare Infection Control Practices Advisory Committee , 2012 .

[2]  D. Harnois,et al.  Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression , 2010 .

[3]  Ryan T Novak,et al.  Hepatitis C Virus Transmission in Hemodialysis Units Importance of Infection Control Practices and Aseptic Technique , 2009, Infection Control & Hospital Epidemiology.

[4]  L. Rostaing,et al.  Mathematical modeling of hepatitis C virus transmission in hemodialysis. , 2009, American journal of infection control.

[5]  O. Djurdjev,et al.  Prevalence and incidence of hepatitis C virus in hemodialysis patients in British Columbia: Follow-up after a possible breach in hemodialysis machines. , 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[6]  P. Patel,et al.  Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008. , 2009, MMWR. Morbidity and mortality weekly report.

[7]  P. Messa,et al.  Transmission of hepatitis C virus infection in hemodialysis: Current concepts , 2008, The International journal of artificial organs.

[8]  Jean-Michel Pawlotsky,et al.  Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Infection control requirements for dialysis facilities and clarification regarding guidance on parenteral medication vials. , 2008, MMWR. Morbidity and mortality weekly report.

[10]  M. Jackson,et al.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.

[11]  Michael P. Busch,et al.  Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates , 2007, Journal of Clinical Microbiology.

[12]  B. Takkouche,et al.  The impact of hepatitis C virus infection on survival in dialysis patients: meta‐analysis of observational studies , 2007, Journal of viral hepatitis.

[13]  A. Davenport,et al.  Travel-associated acquisition of hepatitis C virus infection in patients receiving haemodialysis. , 2007, Nephrology, Dialysis and Transplantation.

[14]  N. Terrault,et al.  The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[15]  M. Alter,et al.  Infectivity of Hepatitis C Virus in Plasma After Drying and Storing at Room Temperature , 2007, Infection Control & Hospital Epidemiology.

[16]  R. Fisher,et al.  Hepatitis C Virus Infection and Kidney Transplantation: Predictors of Patient and Graft Survival , 2007, Transplantation.

[17]  M. Jackson,et al.  Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007. , 2007 .

[18]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[19]  M. Alter,et al.  Factors associated with personal protection equipment use and hand hygiene among hemodialysis staff. , 2006, American journal of infection control.

[20]  G. Salama,et al.  Incidence of HCV infection in French hemodialysis units: A prospective study , 2005, Journal of medical virology.

[21]  S. Glynn,et al.  Dynamics of viremia in early hepatitis C virus infection , 2005, Transfusion.

[22]  J. Desenclos,et al.  A Large Nosocomial Outbreak of Hepatitis C Virus Infections at a Hemodialysis Center , 2005, Infection Control & Hospital Epidemiology.

[23]  M. Alter,et al.  Special Article: National Surveillance of Dialysis‐Associated Diseases in the United States, 2002 , 2005, Seminars in dialysis.

[24]  M. Alter,et al.  Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti‐HCV , 2004, Transfusion.

[25]  M. Polenaković,et al.  Reverse Transcriptase/Polymerase Chain Reaction Analyses of Hemodialysis Ultrafiltrates and Sera of Hepatitis C Virus Positive Patients , 2004, The International journal of artificial organs.

[26]  M. Jadoul,et al.  Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. , 2003, Kidney international.

[27]  E. Nicastri,et al.  Contamination by hepatitis B and C viruses in the dialysis setting. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  M. Alter,et al.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[29]  J. Desenclos,et al.  Outbreak of Hepatitis C Virus Infection in a Hemodialysis Unit: Potential Transmission by the Hemodialysis Machine? , 2002, Infection Control & Hospital Epidemiology.

[30]  M. Alter,et al.  National Surveillance of Dialysis‐Associated Diseases in the United States, 2000 , 2002, Seminars in dialysis.

[31]  B. Casini,et al.  Detection and potential indicators of the presence of hepatitis C virus on surfaces in hospital settings , 2002, Letters in applied microbiology.

[32]  K. Sepkowitz,et al.  High Prevalence of Hepatitis C Infection Among Patients Receiving Hemodialysis at an Urban Dialysis Center , 2002, Infection Control & Hospital Epidemiology.

[33]  H. Margolis,et al.  Hepatitis C virus transmission from an anesthesiologist to a patient. , 2002, Archives of internal medicine.

[34]  S J Henly,et al.  Understanding adherence to hand hygiene recommendations: the theory of planned behavior. , 2001, American journal of infection control.

[35]  G. Ippolito,et al.  Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  S. Saab,et al.  Serum alanine aminotransferase in hepatitis c screening of patients on hemodialysis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  M. Alter,et al.  Recommendations for preventing transmission of infections among chronic hemodialysis patients. , 2001, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[38]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[39]  R. Wiesner,et al.  Predictors of patient and graft survival following liver transplantation for hepatitis C , 1998, Hepatology.

[40]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[41]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[42]  J. Felsenstein,et al.  Estimating effective population size from samples of sequences: a bootstrap Monte Carlo integration method. , 1992, Genetical research.

[43]  J. Devereux,et al.  A comprehensive set of sequence analysis programs for the VAX , 1984, Nucleic Acids Res..

[44]  M. Favero,et al.  SURVIVAL OF HEPATITIS B VIRUS AFTER DRYING AND STORAGE FOR ONE WEEK , 1981, The Lancet.